Revelation Capital Management
Latest statistics and disclosures from Revelation Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are OMDA, ARTV, and represent 100.00% of Revelation Capital Management's stock portfolio.
- Added to shares of these 2 stocks: OMDA (+$82M), ARTV.
- Started 2 new stock positions in OMDA, ARTV.
- Reduced shares in these 3 stocks: Singular Genomics Systems In, AKLI, NPCE.
- Sold out of its positions in AKLI, NPCE, Singular Genomics Systems In.
- Revelation Capital Management was a net buyer of stock by $79M.
- Revelation Capital Management has $84M in assets under management (AUM), dropping by 1860.67%.
- Central Index Key (CIK): 0001801811
Tip: Access up to 7 years of quarterly data
Positions held by Revelation Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Revelation Capital Management
Revelation Capital Management holds 2 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Omada Health (OMDA) | 98.5 | $82M | NEW | 5.2M | 15.78 |
|
| Artiva Biotherapeutics (ARTV) | 1.5 | $1.3M | NEW | 299k | 4.29 |
|
Past Filings by Revelation Capital Management
SEC 13F filings are viewable for Revelation Capital Management going back to 2021
- Revelation Capital Management 2025 Q4 filed Feb. 17, 2026
- Revelation Capital Management 2022 Q3 filed Nov. 7, 2022
- Revelation Capital Management 2022 Q2 filed Aug. 15, 2022
- Revelation Capital Management 2022 Q1 filed May 12, 2022
- Revelation Capital Management 2021 Q4 filed Feb. 14, 2022